Fig. 2: PBMCs phenotype by CyTOF. | Cell Death & Disease

Fig. 2: PBMCs phenotype by CyTOF.

From: Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients

Fig. 2

Intact live cell percentage of T (A), B (B)*, dendritic (C), NK (D) cell subpopulations, and monocytes (E). *Sand-006 patient with chronic lymphatic leukemia (CLL) is not included in (B). HD (n = 3) reveals a partially different populations and subpopulations phenotyping from disease-affected patients, both COV/cancer (n = 5) and COV (n = 6) cohorts. Data represent mean ± SEM. Student’s t test significance has been reported in graphs.

Back to article page